Serina Therapeutics (SER) Receivables - Other (2018 - 2024)
Serina Therapeutics (SER) has disclosed Receivables - Other for 5 consecutive years, with $14000.0 as the latest value for Q3 2024.
- Quarterly Receivables - Other changed N/A to $14000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $14000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $70000.0 for FY2021, 1.41% down from the prior year.
- Receivables - Other hit $14000.0 in Q3 2024 for Serina Therapeutics, down from $51000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $96000.0 in Q2 2021 to a low of $1000.0 in Q2 2020.
- Historically, Receivables - Other has averaged $53888.9 across 3 years, with a median of $70000.0 in 2021.
- Biggest five-year swings in Receivables - Other: plummeted 98.72% in 2020 and later soared 9500.0% in 2021.
- Year by year, Receivables - Other stood at $71000.0 in 2020, then dropped by 1.41% to $70000.0 in 2021, then plummeted by 80.0% to $14000.0 in 2024.
- Business Quant data shows Receivables - Other for SER at $14000.0 in Q3 2024, $51000.0 in Q2 2024, and $70000.0 in Q4 2021.